IMAC Holdings Reports Year End 2022 Financial Results and Corporate Update
Revenue increased 14% annually driven by greater adoption of medical treatments.
BRENTWOOD, Tenn., March 31, 2023 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today reported its financial results for the year ended December 31, 2022.
Related news for (BACK)
- Double Digit Stock Gainers with News: SLXN, SYTA, TRIB, and BACK
- Top Trending Stocks Under $15 Being Traded Today: SYTA, BACK, YIBO, TRIB, ZKIN
- IMAC Holdings Forms Ignite Proteomics to Enhance Personalized Therapy for Cancer Patients
- IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies
- 24/7 Market News Snapshot 27 January, 2025 – IMAC Holdings, Inc. Common Stock (NASDAQ:BACK)